These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 3726784)

  • 1. [Broad-spectrum quinolones (2d-generation quinolones)].
    Neuman M
    Therapie; 1986; 41(2):123-8. PubMed ID: 3726784
    [No Abstract]   [Full Text] [Related]  

  • 2. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
    Schmid DA; Depta JP; Pichler WJ
    Clin Exp Allergy; 2006 Jan; 36(1):59-69. PubMed ID: 16393267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pefloxacin--a laboratory and clinical evaluation of a new quinolone. Based on papers presented at the 14th International Congress of Chemotherapy. Kyoto, Japan, June 1985.
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-118. PubMed ID: 3458695
    [No Abstract]   [Full Text] [Related]  

  • 4. Bacterial resistance to norfloxacin and other newer quinolones: pattern and prospects.
    Nalin DR
    Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S55-61. PubMed ID: 3280327
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new synthetic antibacterial : 1-ethyl-6-fluoro-7-(4-methyl-1-piperazinyl)-4-oxo-1, 4-dihydroquinolin-3-carboxylic acid (1589 R.B.)].
    Goueffon Y; Montay G; Roquet F; Pesson M
    C R Seances Acad Sci III; 1981 Jan; 292(1):37-40. PubMed ID: 6786770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of pefloxacin in combination with other antimicrobial agents.
    Manek N; Wise R; Andrews J
    J Antimicrob Chemother; 1986 Jun; 17(6):827-8. PubMed ID: 3460985
    [No Abstract]   [Full Text] [Related]  

  • 7. Norfloxacin decreases bacterial adherence of quinolone-resistant strains of Escherichia coli isolated from patients with cirrhosis.
    Gascón I; Pascual S; Plazas J; Sánchez J; Francés R; Más P; Zapater P; Pérez-Mateo M; Such J
    Aliment Pharmacol Ther; 2005 Mar; 21(6):701-7. PubMed ID: 15771756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid norfloxacin derivatives as prodrugs.
    Hribar-Kikelj A; Fercej-Temeljotov D; Zmitek J
    Pharmazie; 1993 Jan; 48(1):64-5. PubMed ID: 8460176
    [No Abstract]   [Full Text] [Related]  

  • 9. [Quinolones in 1988].
    Brun-Buisson C
    Rev Prat; 1988 Mar; 38(8):493-500. PubMed ID: 3375770
    [No Abstract]   [Full Text] [Related]  

  • 10. Ciprofloxacin (BAY O 9867). Comparative in vitro activity study.
    Canton E; Garcia J; Vila B; Santos M; Gobernado M
    Microbiol Esp; 1984; 37(3-4):73-9. PubMed ID: 6242123
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
    Croize J; Le Noc P; Bryskier A; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quinolones: historic review].
    Rothlin RP
    Medicina (B Aires); 1999; 59 Suppl 1():3-7. PubMed ID: 10436548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial agents (oxazolidinones, quinolones, macrolides and new agents): patent highlights June to December 2000.
    Phillips OA; Matowe WC
    Curr Opin Investig Drugs; 2001 Jun; 2(6):745-51. PubMed ID: 11572651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of some novel arylthiobenzo[f]quinolines.
    Bahuguna RP; Joshi BC; Mangal HN
    Pharmazie; 1986 Sep; 41(9):672. PubMed ID: 3797464
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of antibacterial activity of norfloxacin and ofloxacin in vitro by serum and experimental pleural exudates.
    Miglioli PA; Sartore P; Gianfranceschi L; Lanzafame P; Berti T
    J Chemother; 1989 Jul; 1(4 Suppl):140-1. PubMed ID: 16312342
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of "oxyn" group compounds as antimicrobial substances against phytopathogenic bacteria].
    Bel'tiukova KI; Koroleva IB; Rotmistrov MM; Kulik GV
    Mikrobiol Zh; 1973; 35(5):635-8. PubMed ID: 4783478
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and antimicrobial activity of ciprofloxacin and norfloxacin permanently bonded to polyethylene glycol by a thiourea linker.
    Pintér G; Horváth P; Bujdosó S; Sztaricskai F; Kéki S; Zsuga M; Kardos S; Rozgonyi F; Herczegh P
    J Antibiot (Tokyo); 2009 Feb; 62(2):113-6. PubMed ID: 19148205
    [No Abstract]   [Full Text] [Related]  

  • 18. Interactions between 4-quinolone antibacterials and multivalent metal ions.
    Smith JT
    J Chemother; 1989 Jul; 1(4 Suppl):134-5. PubMed ID: 16312339
    [No Abstract]   [Full Text] [Related]  

  • 19. [Structure-activity relationships in the quinolone group: antibacterial activity of two new compounds (author's transl)].
    Thibault M; Koumaré B; Soussy CJ; Duval J
    Ann Microbiol (Paris); 1981; 132(3):267-81. PubMed ID: 6457546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of (3S)-amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity and activity against resistant pathogens.
    Hu XE; Kim NK; Gray JL; Almstead JI; Seibel WL; Ledoussal B
    J Med Chem; 2003 Aug; 46(17):3655-61. PubMed ID: 12904069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.